Scott M. Lippman

ORCID: 0000-0002-1643-4124 · 3 papers in corpus · active 1986-2020

Study types

  • article 2
  • review 1

Condition tags

  • endometriosis 1
review 2020
Genome medicine ·doi:10.1186/s13073-020-0714-y

Next-generation sequencing has enabled patient selection for targeted drugs, some of which have shown remarkable efficacy in cancers that have the cognate molecular signatures. Intriguingly, rapidly emerging data indicate that altered genes…

article 1987
·doi:10.1111/j.1600-0609.1987.tb00780.x

20 patients with myelodysplastic syndromes (MDS) were treated with danazol, 800 mg daily in 4 divided doses. 18 patients were evaluable for response. 3 patients (17%), whose principal problem was anemia, responded to treatment, but only wit…

article 1986
·doi:10.1002/ajh.2830230409

Twenty-one unselected patients with refractory chronic anemias of various etiologies were treated with danazol, a synthetic attenuated androgen. All had previously failed treatment with hematinics, androgens, corticosteroids, high-dose intr…